Reaction
Granulomatous Lymphadenitis reporting signals
As of the last recalculation, Granulomatous Lymphadenitis appears in 183 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PYRAZINAMIDE (PRR 101.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pyrazinamide | 8 | 101.3 | 101.3 |
| Polatuzumab Vedotin | 7 | 84.8 | 84.8 |
| Bendamustine Hcl | 7 | 53.3 | 53.4 |
| Pertuzumab | 11 | 48.9 | 48.9 |